특허 및 논문

바이오솔빅스에 자료실을 확인해 보세요.
bt_bb_section_bottom_section_coverage_image

BIOSOLVIX ARCHIVE특허 및 논문

Development of a xeno- free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood.

작성자
관리자
작성일
2024-01-31 16:43
조회
235
Moon SH, Kim SM, Park SJ, Kim H, Bae D, Choi YS, Chung HM. Development of a xeno- free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood. PLoS One. 2013 Sep 248(9):e75224.

Abstract

Despite promising preclinical outcomes in animal models, a number of challenges remain for human clinical use. In particular, expanding a large number of endothelial progenitor cells (EPCs) in vitro in the absence of animal-derived products is the most critical hurdle remaining to be overcome to ensure the safety and efficiency of human therapy. To develop in vitro culture conditions for EPCs derived from human cord blood (hCB-EPCs), we isolated extracts (UCE) and collagen (UC-collagen) from umbilical cord tissue to replace their animal-derived counterparts. UC-collagen and UCE efficiently supported the attachment and proliferation of hCB-EPCs in a manner comparable to that of animal-derived collagen in the conventional culture system. Our developed autologous culture system maintained the typical characteristics of hCB-EPCs, as represented by the expression of EPC-associated surface markers. In addition, the therapeutic potential of hCB-EPCs was confirmed when the transplantation of hCB-EPCs cultured in this autologous culture system promoted limb salvage in a mouse model of hindlimb ischemia and was shown to contribute to attenuating muscle degeneration and fibrosis. We suggest that the umbilical cord represents a source for autologous biomaterials for the in vitro culture of hCB-EPCs. The main characteristics and therapeutic potential of hCB-EPCs were not compromised in developed autologous culture system. The absence of animal-derived products in our newly developed in vitro culture removes concerns associated with secondary contamination. Thus, we hope that this culture system accelerates the realization of therapeutic applications of autologous hCB-EPCs for human vascular diseases.

논문확인(클릭시 이동) 
전체 52
번호 제목 작성자 작성일 추천 조회
12
Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Endothelial Cells in Humanized Mouse Models Harboring a Human Immune
관리자 | 2024.01.31 | 추천 0 | 조회 212
관리자 2024.01.31 0 212
11
Development of a xeno- free autologous culture system for endothelial progenitor cells derived from human umbilical cord blood.
관리자 | 2024.01.31 | 추천 0 | 조회 235
관리자 2024.01.31 0 235
10
The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction
관리자 | 2024.01.31 | 추천 0 | 조회 186
관리자 2024.01.31 0 186
9
Pertussis Toxin Enhances Colony Organization of Enzymatic-dissociated Single Human Embryonic Stem Cells.
관리자 | 2024.01.31 | 추천 0 | 조회 204
관리자 2024.01.31 0 204
8
Effective Method for the Isolation and Proliferation of Primary Lung Cancer Cells from Patient Lung Tissues.
관리자 | 2024.01.31 | 추천 0 | 조회 168
관리자 2024.01.31 0 168
7
Modification of a purification and expansion method for human embryonic stem cell-derived cardiomyocytes.
관리자 | 2024.01.31 | 추천 0 | 조회 183
관리자 2024.01.31 0 183
6
A comparison of human cord blood- and embryonic stem cell-derived endothelial progenitor cells in the treatment of chronic woun
관리자 | 2024.01.31 | 추천 0 | 조회 185
관리자 2024.01.31 0 185
5
Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo.
관리자 | 2024.01.31 | 추천 0 | 조회 231
관리자 2024.01.31 0 231
4
A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation.
관리자 | 2024.01.31 | 추천 0 | 조회 261
관리자 2024.01.31 0 261
3
Gene Expression Profiles in CHA3 and CHA4 Human Embryonic Stem Cells and Embryoid Bodies
관리자 | 2024.01.31 | 추천 0 | 조회 218
관리자 2024.01.31 0 218